Filing Details

Accession Number:
0001567619-22-005791
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-28 16:50:45
Reporting Period:
2022-02-25
Accepted Time:
2022-02-28 16:50:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1829802 Sensei Biotherapeutics Inc. SNSE () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1797409 Cambrian Biopharma Inc 19 Morris Avenue
Brooklyn Navy Yard, Building 128
Brooklyn NY 11205
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-02-25 2,500 $3.65 5,228,286 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. These shares are held by Cambrian Biopharma, Inc., a Delaware corporation ("Cambrian"). The Chief Executive Officer of Cambrian, James Peyer, may direct the voting and disposition of the shares held by Cambrian, subject in certain instances to the approval of Cambrian's Board of Directors. Mr. Peyer disclaims beneficial ownership of such shares.